BioStem Technologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Company Overview - BioStem Technologies, Inc. is a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care [4] - The company utilizes its proprietary BioREtain® processing method to maintain growth factors and preserve tissue structure in its products [4] - BioStem's quality management system has been accredited by the American Association of Tissue Banks (AATB) and adheres to current Good Tissue Practices (cGTP) and current Good Manufacturing Processes (cGMP) [4] Recent Developments - BioStem Technologies will participate in the Goldman Sachs 46th Annual Global Healthcare Conference in Miami [1] - Jason Matuszewski, the CEO, will engage in a fireside chat and is available for one-on-one meetings with conference attendees [2] Product Portfolio - The company's product brands include AmnioWrap2™, VENDAJE, VENDAJE AC, and VENDAJE OPTIC, all processed at its FDA registered and AATB accredited site in Pompano Beach, Florida [4]